Breakthrough infections greatly enhance immune response to variants of the virus that causes COVID-19, according to new research. The study is the first to use live SARS-CoV-2 variants to measure cross-neutralization of blood serum from breakthrough cases, portending an eventual ‘end game’ to the pandemic.
